Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study

被引：0
|
作者：
Hadden, R. [1 ]
Andersen, H. [2 ]
Bril, V. [3 ]
Basta, I. [4 ]
Rejdak, K. [5 ]
Djordjevic, G. [6 ]
Greco, E. [7 ]
Hasan, S. [7 ]
French, J. [7 ]
Yel, L. [7 ]
Ay, H. [7 ]
机构：
[1] Kings Coll Hosp London, Dept Neurol, London, England
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[4] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Fac Med, Belgrade, Serbia
[5] Med Univ Lublin, Dept Neurol, Lublin, Poland
[6] Univ Clin Ctr Nis, Neurol Clin, Nish, Serbia
[7] Takeda Dev Ctr Amer Inc, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-244
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [31] Long-term effects of intravenous immunoglobulin in CIDP
    Vucic, S.
    Black, K.
    Baldassari, L. E.
    Chong, P. Siao Tick
    Dawson, K. T.
    Cros, D.
    CLINICAL NEUROPHYSIOLOGY, 2007, 118 (09) : 1980 - 1984
  • [32] Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies
    Kobayashi, Roger H.
    Litzman, Jiri
    Melamed, Isaac
    Mandujano, J. Fernando
    Kobayashi, Ai Lan
    Ritchie, Bruce
    Geng, Bob
    Atkinson, T. Prescott
    Rehman, Syed
    Hoeller, Sonja
    Turpel-Kantor, Eva
    Kreuwel, Huub
    Speer, J. C.
    Gupta, Sudhir
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 210 (02): : 91 - 103
  • [33] PATIENT-REPORTED OUTCOMES WITH HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% AND INTRAVENOUS IMMUNOGLOBULIN 10%: THE ADVANCE-CIDP 1 STUDY
    Anderson-Smits, Colin
    Ay, Hakan
    Greco, Erin
    Hasan, Shabbir
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S81 - S81
  • [34] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S57 - S57
  • [35] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [36] Long-term safety and efficacy of subcutaneous imunoglobulin IgPro20 in CIDP: The PATH extension study
    van Schaik, Ivo
    Mielke, Orell
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard
    Sobue, Gen
    Lawo, John-Philip
    Praus, Michaela
    Durn, Billie
    Cornblath, David
    Merkies, Ingemar
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 294 - 295
  • [37] POPULATION PHARMACOKINETIC SIMULATIONS IN CIDP AND MMN: HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN AND INTRAVENOUS IMMUNOGLOBULIN G 10%
    Freedman, Immanuel
    Roepcke, Stefan
    Li, Zhaoyang
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S91 - S92
  • [38] LONG-TERM SAFETY, EFFICACY, AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN PATIENTS AGED ≥16 YEARS WITH PRIMARY IMMUNODEFICIENCIES
    Wasserman, R. L.
    Stein, M.
    Kobrynski, L.
    Gupta, S.
    Grant, J.
    Rubinstein, A.
    Engl, W.
    McCoy, B.
    Leibl, H.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A103 - A103
  • [39] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Howard, James
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    NEUROLOGY, 2023, 100 (17)
  • [40] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT-SC plus STUDY
    Li, Yuebing
    Howard, James F., Jr.
    Vu, Tuan
    Korobko, Denis
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Hodari, Moana
    Utsugisawa, Kimiaki
    Sacca, Francesco
    De Bleecker, Jan L.
    Mantegazza, Renato
    MUSCLE & NERVE, 2024, 70 (03) : 559 - 560
12345